Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 9, 2023
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
[ Wed, Aug 09th 2023
] - WOPRAI
Max Masucci Maintained (BLFS) at Buy with Decreased Target to $25 on, Aug 9th, 2023
Max Masucci of TD Cowen, Maintained "BioLife Solutions, Inc." (BLFS) at Buy with Decreased Target from $29 to $25 on, Aug 9th, 2023.
Max has made no other calls on BLFS in the last 4 months.
There are 2 other peers that have a rating on BLFS. Out of the 2 peers that are also analyzing BLFS, 0 agree with Max's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Max
- Jacob Johnson of "Stephens & Co." Maintained at Buy with Increased Target to $29 on, Monday, July 17th, 2023
- Matt Hewitt of "Craig-Hallum" Initiated at Strong Buy and Held Target at $29 on, Tuesday, July 11th, 2023
